Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AF

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 104 participants.

Also called NCT01817439

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 104 participants (planned count) (from the registry)
Sponsor
Western Galilee Hospital-Nahariya (from the registry)
Registry
  • NCT NCT01817439
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Israel (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01817439. Randomized; no masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2015-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AF
Intervention (Drug)
Amiodarone
Lead sponsor
Western Galilee Hospital-Nahariya (class: other government)

Record details

Record id
cardio:ct-nct01817439
Content hash
7886df9d95c45265df9f465a0cede022adf5c4974e3f6fb84f4fcce641459395